This inventor holds 2 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Adc Therapeutics Sa, Medimmune Limited, Medimmune Limtied. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 21 
1 out of 548 
1 out of 1 Years Active: 2020-2023
Title: Francesca Zammarchi: Innovator in Combination Therapies
Introduction
Francesca Zammarchi is a prominent inventor based in Epalinges, Switzerland. She has made significant contributions to the field of medicine, particularly in the development of combination therapies for treating cancer. With a total of 2 patents, her work is paving the way for innovative treatment options.
Latest Patents
Zammarchi's latest patents include groundbreaking research on combination therapies. The first patent focuses on a combination therapy with an anti-CD25 antibody-drug conjugate. This patent relates to therapies aimed at treating pathological conditions, such as cancer, by utilizing an Antibody Drug Conjugate (ADC) alongside a secondary agent. The second patent also addresses combination therapy, specifically with an anti-axl antibody-drug conjugate, further emphasizing her commitment to advancing cancer treatment through innovative approaches.
Career Highlights
Throughout her career, Francesca Zammarchi has worked with notable companies, including ADC Therapeutics SA and MedImmune Limited. Her experience in these organizations has allowed her to collaborate on various projects that enhance the understanding and treatment of cancer.
Collaborations
Zammarchi has collaborated with esteemed colleagues, including Patricius Hendrikus Cornelis Van Berkel and Jens Wuerthner. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Francesca Zammarchi is a trailblazer in the field of combination therapies, with her innovative patents and collaborations significantly impacting cancer treatment. Her work continues to inspire advancements in medical research and therapy development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile